LIM homeobox transcription factor 1 alpha (LMX1A)

**LIM homeobox transcription factor 1 alpha (LMX1A)** is a DNA-binding transcription factor containing two LIM domains and a C-terminal homeodomain[4]. It acts as a positive regulator of insulin gene transcription by binding to A/T-rich elements in the insulin gene promoter, thereby influencing insulin production in pancreatic beta cells[1][6]. LMX1A is also crucial for nervous system development, including the specification of dorsal cell fates in the CNS, roof plate development, and the differentiation of dopamine-producing neurons during embryogenesis. Mutations in LMX1A are associated with human diseases such as deafness (DFNA7), sensorineural hearing loss, and increased risk of Parkinson's disease[3][2]. LMX1A belongs to the LHX protein family and functions broadly in cell fate determination and tissue patterning across vertebrates[4][2][3]. No interacting drugs, drug mechanisms, or established biomarker roles are reported for this factor; it is not a conventional therapeutic target but a developmental and disease-associated transcription factor.

Other names

LIM homeobox transcription factor 1-alphaLMX1ALMX-1.1LMX1.1LIM/homeobox protein 1.1LIM/homeobox protein LMX1ADFNA7LMX1dreher